Prescient Therapeutics LimitedASX: PTX

PTX Opens First Clinical site for PTX-100 Phase 2a Study

Mar 26, 2025 at 2:14 AM UTC · Issued by Prescient Therapeutics Limited

Prescient Therapeutics Ltd has released a press release.

View Attachment